跳至主要内容
临床试验/JPRN-jRCTs031220564
JPRN-jRCTs031220564
尚未招募
未知

A single-arm intervention trial to verify the efficacy of mAb114 against Ebola virus disease. - mAb-EVD

Morioka Shinichiro0 个研究点目标入组 5 人2023年6月1日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Ebola virus disease
发起方
Morioka Shinichiro
入组人数
5
状态
尚未招募
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2023年6月1日
结束日期
待定
最后更新
2年前
研究类型
Interventional
性别
All

研究者

发起方
Morioka Shinichiro

入排标准

入选标准

  • 1\) Subjects who have given written informed consent to participate in the study
  • 2\) Subjects whose EV RNA was detected by reverse\-transcriptase\-polymerase\-chain\-reaction assay (RT\-PCR) test using blood, urine, or throat swab samples.

排除标准

  • 1\) Persons who are judged inappropriate for inclusion in this research by the research representative or co\-investigators
  • 2\) Subjects who are considered inappropriate for administration based on the package insert or documents equivalent to the investigator's brochure
  • (3\) Patients who have had a severe hypersensitivity reaction to Clozapine should not be administered the drug.

结局指标

主要结局

未指定

相似试验